EFFECTIVENESS OF CHITOSAN NANOPARTICLE CONTAINING 0.7% TETRACYCLINES ON CLINICAL PARAMETERS AND FIBROBLAST GROWTH: FACTOR-2 IN RAT MODELS

SILVIA; IRMA ERVINA; MARTINA AMALIA; ERDI EFFENDI NASUTION; HARRY AGUSNAR; PITU WULANDARI; RINI OCTAVIA NASUTION

doi:10.22159/ijap.2024.v16s2.10

Authors

SILVIA Department of Periodontics, Faculty of Dentistry, Universitas Sumatera Utara, Medan, Indonesia
IRMA ERVINA Department of Periodontics, Faculty of Dentistry, Universitas Sumatera Utara, Medan, Indonesia https://orcid.org/0000-0002-8705-4022
MARTINA AMALIA Department of Periodontics, Faculty of Dentistry, Universitas Sumatera Utara, Medan, Indonesia https://orcid.org/0000-0003-3252-2033
ERDI EFFENDI NASUTION Department of Periodontics, Faculty of Dentistry, Universitas Sumatera Utara, Medan, Indonesia
HARRY AGUSNAR Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Sumatera Utara, Medan, Indonesia
PITU WULANDARI Department of Periodontics, Faculty of Dentistry, Universitas Sumatera Utara, Medan, Indonesia
RINI OCTAVIA NASUTION Department of Periodontics, Faculty of Dentistry, Universitas Sumatera Utara, Medan, Indonesia https://orcid.org/0009-0005-4160-3806

DOI:

https://doi.org/10.22159/ijap.2024.v16s2.10

Keywords:

Chitosan nanoparticle containing, Fibroblast growth

Abstract

Objective: Tetracyclines in periodontitis improved probing depth, increased attachment level, and reduced bacterial colonies. Chitosan nanoparticles have slower drug release, better drug stability, and lower toxicity. This study is to evaluate the effectiveness of subgingival application of chitosan nanoparticles containing 0.7% tetracyclines in the periodontitis model on clinical parameters and fibroblast growth factor-2 (FGF-2) expression.

Methods: Laboratory experimental research on 29 Wistar rats induced by p. gingivalis with pretest posttest control group design, divided into 4 treatment groups, 2 placebo groups, and 1 negative control group. Clinical parameters of bleeding on probing (BOP) and Pocket Depth (PD) and FGF-2 expression were evaluated on day 3 and 8.

Results: Significant decrease in BOP was only found in the daily application group of chitosan nanoparticles containing 0.7% tetracyclines on day 8 (p=0.008) and significant decrease in mean PD was found in the application group of chitosan nanoparticles containing 0.7% tetracyclines every day (p=0.034) or once only (p=0.046). FGF-2 expression increased on day 3 of each group and decreased on day 8 of each group. Significant difference in the FGF-2 expression was found in all groups on day 3 (p=0.034) but it was only between the daily application group and the once only application group (p=0.012).

Conclusion: There was a decrease in the percentage of BOP and PD in all groups as well as a significant increase in FGF-2 expression on day 3 and 8 after the application of chitosan nanoparticles containing 0.7% tetracyclines.

Downloads

Download data is not yet available.

References

Joshi D, Garg T, Goyal AK, Rath G. Advanced drug delivery approaches against periodontitis. Drug Deliv. 2016;23(2):363-77. doi: 10.3109/10717544.2014.935531, PMID 25005586.

Nazir MA. Prevalence of periodontal disease, its association with systemic diseases and prevention. Int J Health Sci (Qassim). 2017;11(2):72-80. PMID 28539867.

http://www.ncbi.nlm.nih.gov/pubmed/28539867%0A, http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC5426403 [Last accessed on 18 Apr 2024]

Kementerian Kesehatan Republik Indonesia. Laporan nasional riset kesehatan dasar. Kementeri Kesehat RI; 2018. p. 1-582.

Prakasam A, Elavarasu SS, Natarajan RK. Antibiotics in the management of aggressive periodontitis. J Pharm Bioallied Sci. 2012;4Suppl 2:S252-5. doi: 10.4103/0975-7406.100226, PMID 23066264.

Sinha S, Kumar S, Dagli N, Dagli RJ. Effect of tetracycline HCl in the treatment of chronic periodontitis-a clinical study. J Int Soc Prev Community Dent. 2014;4(3):149-53. doi: 10.4103/2231-0762.142011, PMID 25374831.

Sharma NK, Prasad A. Evaluation of efficacy of tetracyclines as a local drug delivery system in the treatment of chronic periodontitis as an adjunct to scaling adn root planing: A clinical and microbiological study. Int J Contemp Med Res. 2017;4(5):998-1003.

Ahmed S, Ikram S. Chitosan based scaffolds and their applications in wound healing. Achiev Life Sci. 2016;10(1):27-37. doi: 10.1016/j.als.2016.04.001.

Dinu Pirvu E. Periodontal chitosan-gels designed for improved local intra-pocket drug delivery. FARMACIA. 2013;61:240-50.

Susanto C, Ervina I, Agusnar H. In vitro evaluation of antimicrobial effectiveness chitosan based tetracyclines gel on some pathogenic periodontal bacteria. Int J Appl Dent Sci. 2017;3(2):71-6.

Andrew A, Ervina I, Agusnar H. In vitro chitosan hydrogel based tetracycline cytotoxicity test on fibroblast viability. Advances in Health Sciences Research. 2018;4:265-72. doi: 10.2991/idsm-17.2018.36.

Astuti WD. Jumlah sel fibroblas pada ligamen periodontal setelah skeling dan penghalusan akar disertai aplikasi tetrasiklin 0,7% berbasis hidrogel kitosan pada model periodontitis (in vivo) [tesis]. Medan: Universitas Sumatera Utara; 2020.

Puri K, Puri N. Local drug delivery agents as adjuncts to endodontic and periodontal therapy. J Med Life. 2013;6(4):414-9. PMID 24868252.

El-Alfy EA, El-Bisi MK, Taha GM, Ibrahim HM. Preparation of biocompatible chitosan nanoparticles loaded by tetracycline, gentamycin and ciprofloxacin as novel drug delivery system for improvement the antibacterial properties of cellulose based fabrics. Int J Biol Macromol. 2020;161:1247-60. doi: 10.1016/j.ijbiomac.2020.06.118, PMID 32553963.

Mohammed MA, Syeda JT, Wasan KM, Wasan EK. An overview of chitosan nanoparticles and its application in non-parenteral drug delivery. Pharmaceutics. 2017;9(4). doi: 10.3390/pharmaceutics9040053, PMID 29156634.

Oentaryo G, Istiati I, Soesilawati P. Acceleration of fibroblast number and FGF-2 expression using Channa striata extract induction during wound healing process: in vivo studies in wistar rats. Dent J (Majalah Kedokteran Gigi). 2016;49(3):125-32. doi: 10.20473/j.djmkg.v49.i3.p125-132.

Salomao MF, Reis SR, Vale VL, Machado CV, Meyer R, Nascimento IL. Immunolocalization of FGF-2 and VEGF in rat periodontal ligament during experimental tooth movement. Dental Press J Orthod. 2014;19(3):67-74. doi: 10.1590/2176-9451.19.3.067-074.oar, PMID 25162568.

Matesanz-pe P, Garcı M, Figuero E, Bascones Martı A, Sanz M, Matesanz Pe P. A systematic review on the effects of local antimicrobials as adjuncts to subgingival debridement, compared with subgingival debridement alone, in the treatment of chronic periodontitis. J Clin Periodontol. 2013;40(3):227-41. doi: 10.1111/jcpe.12026

Killeen AC, Harn JA, Erickson LM, Yu F, Reinhardt RA. Local minocycline effect on inflammation and clinical attachment during periodontal maintenance: randomized clinical trial. Randomized Clinical Trial. 2016;87(10):1149-57. doi: 10.1902/jop.2016.150551.

Tandiono S. Pembuatan dan evaluasi suspensi nanopartikel kitosan–natrium tripolifosfat sebagai antibakteri (Skripsi). Medan: Universitas Sumatera Utara; 2018.

Dukka H, Saleh MH, Ravida A, Greenwell H, Wang HL. Is bleeding on probing a reliable clinical indicator of peri-implant diseases? J Periodontol. 2021;92(12):1669-74. doi: 10.1002/JPER.20-0890, PMID 33829501.

Rovai ES, Souto ML, Juliana A. Efficacy of local antimicrobials in the nonsurgical treatment of periodontitis patients with diabetes: a systematic review. J Periodontol. 2016;87(12):1406-17. doi: 10.1902/jop.2016.160214

Chambrone L, Vargas M, Arboleda S, Serna M. Efficacy of local and systemic antimicrobials in the nonsurgical treatment of smokers with chronic periodontitis: A. Syst Rev. 2016;87(11):15-8.

Li J, Zhuang S. Antibacterial activity of chitosan and its derivatives and their interaction mechanism with bacteria: current state and perspectives. Eur Polym J 2020;138:109984. doi: 10.1016/j.eurpolymj.2020.109984.

He J, Da L, Pan Y, Tan X, Li Z, Luo F. Association between quantitative analyses of periodontal pathogens and the depth of periodontal pockets. Biotechnol Biotechnol Equip. 2020;34(1):515-21. doi: 10.1080/13102818.2020.1764387.

Kaur M, Geurs NC, Cobb CM, Otomo Corgel J, Takesh T, Lee JH. Evaluating efficacy of a novel dentifrice in reducing probing depths in Stage I and II periodontitis maintenance patients: a randomized, double-blind, positive controlled clinical trial. J Periodontol. 2021;92(9):1286-94. doi: 10.1002/JPER.20-0721, PMID 33331040.

Cobb CM, Sottosanti JS. A re-evaluation of scaling and root planing. J Periodontol. 2021;92(10):1370-8. doi: 10.1002/JPER.20-0839, PMID 33660307.

Wilson. Per anan scaling-root planing disertai aplikasi subgingiva tetrasiklin 0,7% berbasis hidrogel kitosan pada model periodontitis tikus: evaluasi parameter klinis dan jumlah sel fibroblas pada ligamen periodontal [tesis]. Medan: Universitas Sumatera Utara; 2020.

Nayak S, Goel MM, Makker A, Bhatia V, Chandra S, Kumar S. Fibroblast growth factor (FGF-2) and its receptors FGFR-2 and FGFR-3 may be putative biomarkers of malignant transformation of potentially malignant oral lesions into oral squamous cell carcinoma. PLOS ONE. 2015;10(10):e0138801. doi: 10.1371/journal.pone.0138801, PMID 26465941.

Franco EJ, Pogue RE, Sakamoto LH, Cavalcante LL, de Carvalho DR, de Andrade RV. Increased expression of genes after periodontal treatment with photodynamic therapy. Photodiagnosis Photodyn Ther. 2014;11(1):41-7. doi: 10.1016/j.pdpdt.2013.10.002, PMID 24184796.

Nagayasu Tanaka T, Anzai J, Takaki S, Shiraishi N, Terashima A, Asano T. Action mechanism of fibroblast growth factor-2 (FGF-2) in the promotion of periodontal regeneration in beagle dogs. Plos One. 2015;10(6):e0131870. doi: 10.1371/journal. pone.0131870, PMID 26120833.